About Ono


Gyo Sagara / President, Representative Director and CEO


ONO has taken a new step beyond the major milestone of the 300th anniversary, since its establishment  in 1717 as an apothecary by Ichibei Fushimiya in Doshomachi, Osaka. 
We would like to express our sincere gratitude for all your continuous great support and assistance.

Upholding the corporate philosophy “Dedicated to Man’s Fight against Disease and Pain,” we make united efforts to create innovative drugs that are globally competitive. Optimizing our strengths with an eye to the future, we are in active pursuit of becoming “Global Specialty Pharma,” an R&D-oriented global pharmaceutical company specialized in particular areas.

ONO focuses on drug discovery leads that are high in certainty and globally competitive. Capitalizing on the technologies and know-how nurtured through our research history, we propel drug development in areas where we can continue to optimize our strengths and in areas where we can effectively utilize the genes we possess as our genetic assets in the field of genomic drug discovery. We are in active pursuit of the discovery and development of drugs that meet the unmet medical needs at the frontline of healthcare.

By strengthening strategic alliances globally, we endeavor to bolster our drug discovery capability, introducing breakthrough drug discovery seeds and leading-edge technologies from biopharmaceutical companies, as well as academic and other research establishments in Europe and the USA.

We are constantly expanding our development pipeline, directing our efforts toward licensing activities such as the in-licensing of new drug candidates.

Under this R&D policy, we are committed to enhancing our corporate social value through the continued development and commercialization of "drugs that deliver true benefit to patients." We are ready and poised to tackle the global market, armed with all our strengths.

Gyo Sagara
President, Representative Director, and CEO